Mentat
Mentat is a mental fitness formula that supports brain function in both normal and demanding situations.
| Product dosage: 60caps | |||
|---|---|---|---|
| Package (num) | Per bottle | Price | Buy |
| 2 | $28.00 | $56.00 (0%) | 🛒 Add to cart |
| 3 | $26.33 | $84.00 $79.00 (6%) | 🛒 Add to cart |
| 4 | $25.25 | $112.00 $101.00 (10%) | 🛒 Add to cart |
| 5 | $24.60 | $140.00 $123.00 (12%) | 🛒 Add to cart |
| 6 | $24.33 | $168.00 $146.00 (13%) | 🛒 Add to cart |
| 7 | $24.00 | $196.00 $168.00 (14%) | 🛒 Add to cart |
| 8 | $23.88 | $224.00 $191.00 (15%) | 🛒 Add to cart |
| 9 | $23.67 | $252.00 $213.00 (15%) | 🛒 Add to cart |
| 10 | $23.60
Best per bottle | $280.00 $236.00 (16%) | 🛒 Add to cart |
Similar products
More info:
Bupropion: A Leading Antidepressant for Depression and Smoking Cessation
Bupropion is a widely prescribed antidepressant medication belonging to the class of norepinephrine-dopamine reuptake inhibitors (NDRIs). It is primarily indicated for the treatment of major depressive disorder (MDD) and to aid in smoking cessation. Unlike many other antidepressants, bupropion does not significantly affect serotonin levels, which contributes to its distinct side effect profile and makes it a favorable option for patients who cannot tolerate serotonergic agents. Its dual mechanism of action enhances norepinephrine and dopamine neurotransmission, which is associated with improvements in mood, energy, and motivation.
Isoniazid: The Gold Standard in Tuberculosis Treatment
Isoniazid, also known by its common brand name Nydrazid, is a first-line antibacterial agent specifically indicated for the treatment and prevention of all forms of active and latent tuberculosis (TB) infection caused by susceptible strains of Mycobacterium tuberculosis. As a cornerstone of modern anti-tuberculosis therapy, it is one of the most effective and essential medications in global public health efforts to control and eradicate this infectious disease. Its mechanism of action involves the inhibition of mycolic acid synthesis, a critical component of the mycobacterial cell wall, leading to bactericidal activity against actively dividing organisms and bacteriostatic effects against dormant bacilli.
Mellaril: Advanced Neuroleptic Therapy for Schizophrenia Management
Mellaril (thioridazine hydrochloride) is a first-generation phenothiazine antipsychotic medication indicated for the management of manifestations of schizophrenia in patients who have not responded adequately to treatment with other antipsychotic drugs. As a potent dopamine D2 receptor antagonist, it exerts its primary therapeutic effect by blocking postsynaptic mesolimbic dopaminergic receptors in the brain, thereby reducing the positive symptoms of psychosis, including hallucinations, delusions, and thought disorder. Its use requires careful patient selection and vigilant monitoring due to its specific side effect profile, particularly concerning cardiac conduction abnormalities.
Thorazine: Restoring Stability in Severe Psychiatric and Medical Conditions
Thorazine (chlorpromazine hydrochloride) is a first-generation typical antipsychotic medication belonging to the phenothiazine class. It represents a cornerstone in psychopharmacology, primarily indicated for the management of manifestations of psychotic disorders, such as schizophrenia. Its efficacy extends beyond psychiatry, serving as a potent antiemetic for severe nausea and vomiting and as an adjunct in the treatment of intractable hiccups. This agent works by blocking postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain, alongside antagonizing adrenergic, cholinergic, and histaminergic receptors, which contributes to both its therapeutic effects and its side effect profile.
Abilify: Advanced Antipsychotic for Symptom Control and Stability
Abilify (aripiprazole) is an atypical antipsychotic medication engineered to provide a sophisticated mechanism of action for managing complex psychiatric conditions. It functions as a partial agonist, offering a unique modulatory effect on dopamine and serotonin receptors, which contributes to its efficacy and generally favorable tolerability profile. This medication is a cornerstone in the long-term management of schizophrenia, bipolar disorder, and as an adjunct in major depressive disorder, providing patients with a path toward sustained symptom control and improved functional outcomes.
Amitriptyline: Effective Relief for Chronic Pain and Depression
Amitriptyline is a tricyclic antidepressant (TCA) with a well-established profile for managing major depressive disorder and a range of chronic pain conditions. Its dual-action mechanism modulates serotonin and norepinephrine reuptake, offering both mood stabilization and central pain modulation. It is particularly valued in clinical practice for its efficacy in neuropathic pain, migraine prophylaxis, and as a second-line option for depression when SSRIs are ineffective or poorly tolerated. This product card provides a comprehensive, evidence-based overview for healthcare professionals.
Anafranil: Restoring Balance in Severe OCD Treatment
Anafranil (clomipramine hydrochloride) is a tricyclic antidepressant (TCA) with potent serotonin reuptake inhibition properties, specifically approved for the treatment of obsessive-compulsive disorder (OCD). It represents a foundational pharmacological intervention for moderate to severe OCD cases where first-line treatments prove insufficient. Its efficacy is well-documented in clinical literature, offering a robust option for patients struggling with intrusive thoughts and compulsive behaviors. By modulating key neurotransmitter systems, it helps reduce the core symptoms that significantly impair daily functioning and quality of life.
Asendin: Targeted Relief for Endogenous Depression with Dual-Action Efficacy
Asendin (amoxapine) is a tetracyclic antidepressant (TeCA) medication indicated for the relief of symptoms of endogenous depression. It represents a distinct class of agent that combines potent norepinephrine reuptake inhibition with secondary dopamine receptor blockade, offering a unique neurochemical profile for cases where first-line selective serotonin reuptake inhibitors (SSRIs) prove inadequate or intolerable. Its mechanism provides a rapid onset of action for certain symptoms, particularly psychomotor retardation, often within the first week of treatment.
Bupropion SR: Effective Relief for Major Depressive Disorder
Bupropion SR (sustained-release) is a widely prescribed antidepressant belonging to the aminoketone class, distinct from SSRIs and SNRIs. It functions primarily as a norepinephrine–dopamine reuptake inhibitor (NDRI), offering a unique mechanism of action for managing major depressive disorder. This formulation provides steady plasma concentrations over 12 hours, supporting consistent therapeutic effect with twice-daily dosing. Clinicians often favor bupropion SR for its favorable side effect profile, particularly the low incidence of sexual dysfunction and weight gain associated with other antidepressants.